Recombinant multi-species REL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine REL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that belongs to the Rel homology domain/immunoglobulin-like fold, plexin, transcription factor (RHD/IPT) family. Members of this family regulate genes involved in apoptosis, inflammation, the immune response, and oncogenic processes. This proto-oncogene plays a role in the survival and proliferation of B lymphocytes. Mutation or amplification of this gene is associated with B-cell lymphomas, including Hodgkin's lymphoma. Single nucleotide polymorphisms in this gene are associated with susceptibility to ulcerative colitis and rheumatoid arthritis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2014]
The Alternative Names of target: C-Rel,HIVEN86A,IMD92,Proto-oncogene c-Rel,REL,Rel,c-Rel
Go
to REL products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T22547-Ag-1/ GM-Tg-hg-T22547-Ag-2 | Human REL protein | Human |
| GM-Tg-rg-T22547-Ag-1/ GM-Tg-rg-T22547-Ag-2 | Rat REL protein | Rat |
| GM-Tg-mg-T22547-Ag-1/ GM-Tg-mg-T22547-Ag-2 | Mouse REL protein | Mouse |
| GM-Tg-cynog-T22547-Ag-1/ GM-Tg-cynog-T22547-Ag-2 | Cynomolgus/Rhesus macaque REL protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T22547-Ag-1/ GM-Tg-felg-T22547-Ag-2 | Feline REL protein | Feline |
| GM-Tg-cang-T22547-Ag-1/ GM-Tg-cang-T22547-Ag-2 | Canine REL protein | Canine |
| GM-Tg-bovg-T22547-Ag-1/ GM-Tg-bovg-T22547-Ag-2 | Bovine REL protein | Bovine |
| GM-Tg-equg-T22547-Ag-1/ GM-Tg-equg-T22547-Ag-2 | Equine REL protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T22547-Ag-1/ GM-Tg-hg-T22547-Ag-2;
GM-Tg-rg-T22547-Ag-1/ GM-Tg-rg-T22547-Ag-2;
GM-Tg-mg-T22547-Ag-1/ GM-Tg-mg-T22547-Ag-2; GM-Tg-cynog-T22547-Ag-1/ GM-Tg-cynog-T22547-Ag-2; GM-Tg-felg-T22547-Ag-1/ GM-Tg-felg-T22547-Ag-2; GM-Tg-cang-T22547-Ag-1/ GM-Tg-cang-T22547-Ag-2; GM-Tg-bovg-T22547-Ag-1/ GM-Tg-bovg-T22547-Ag-2; GM-Tg-equg-T22547-Ag-1/ GM-Tg-equg-T22547-Ag-2 |
| Products Name | REL protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | REL |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine REL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.